TTR Amyloidosis Phase IIa results will be presented by Dr. Josep Gàmez at AAN 2016 Annual Meeting to be held in Vancouver (Canada) from 15th to 21th of April. This Clinical Trial has been performed by SOM Biotech and VHIR (Vall d’Hebron Hospital Institute of Research).

Further information about the meeting at AAN 2016 Annual Meeting